Obalon Therapeutics, Inc.
USD3.05
-0.19 (-5.86%)
CEO
Kelly Huang
IPO Date
2016-10-06
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$3.25
Prev. Close
$3.24
Day Low
$2.95
Day High
$4.80
52W Low
$1.98
52W High
$32.31
Market Cap
$0.01B
Volume
26.47M
| 27,250 |
| $0.77 |
| 18 Sept 2020 | Stevenson Sharon | director | A-Award | Acquired | 27,250 | $0.00 |
| 18 Sept 2020 | Stevenson Sharon | director | A-Award | Acquired | 27,250 | $0.77 |
| 25 Jun 2020 | Hussainy Nooshin | Chief Financial Officer | A-Award | Acquired | 165,135 | $0.73 |
| 25 Jun 2020 | Hussainy Nooshin | Chief Financial Officer | A-Award | Acquired | 52,865 | $0.00 |
| 25 Jun 2020 | Rasdal Andrew P | director, officer: President, CEO & Exec Chairman | A-Award | Acquired | 165,135 | $0.73 |
| 25 Jun 2020 | Rasdal Andrew P | director, officer: President, CEO & Exec Chairman | A-Award | Acquired | 52,865 | $0.00 |
| 28 Jan 2020 | Hussainy Nooshin | Chief Financial Officer | A-Award | Acquired | 88,225 | $0.00 |
| 28 Jan 2020 | VandenBerg Amy | Chief Clinical & Reg Officer | A-Award | Acquired | 88,225 | $0.00 |